Cirrhosis Quality Collaborative (CQC) - Learning Session II

5 (1 vote)

Recorded On: 10/19/2021

DESCRIPTION
The Cirrhosis Quality Collaborative (CQC) adopts monthly calls and full or half-day learning session events that invite improvement team representatives from all CQC member sites to convene for the purposes of learning and sharing in the pursuit of CQC improvement goals. While specific learning objectives are emergent and shaped by the evolving needs of members over the course of the CQC, common features of these calls include peer-to-peer sharing, relevant care model and change ideas, improvement and implementation strategy, review and analysis of improvement data, and emerging news and resources that are directly relevant to the improvement aims. 

KEY TOPIC AREA
Improvement strategies utilized to change processes and systems at participating hospital sites within the CQC learning network. 

CME INTERNET LIVE ACTIVITY
Release date:
 October 19, 2021
Expiration date: October 19, 2021
Time in internet live activity: up to 1.50 hours

CME and CE INTERNET ENDURING ACTIVITY (Available)
Release date: December 20, 2021
Expiration date: December 19, 2024
Previously recorded: October 19, 2021
Time to complete internet enduring activity: up to 1.50 hours

CREDITS OFFERED
Continuing Medical Education (CME): For a maximum of 1.50 AMA PRA Category 1 Credits™  
Continuing Education (CE): For a maximum of 1.50 Contact Hour**  
You may only earn one Continuing Education Credit type - either CME or CE

COMPONENTS
On-demand webinar series comprised of:

- 1.50 hour session in length
-Evaluation for CME or CE credit offering 

DIRECTIONS
Click "Register" to activate the enduring material. Review all section tabs before you begin. Select session of interest. Complete all components to claim either CME or CE. 

COPYRIGHT 
All faculty in this activity have given their permission for publication ©2021 AASLD. 

CONTACT INFORMATION 
For questions on CME content or LiverLearning®, contact online_education@aasld.org 
For questions on CE credit for this enduring material, contact Certificate@AmedcoEmail.com

**CME AMA PRA Category 1 Credits™ and CE Contact Hours will be available for on-demand/internet enduring activity beginning December 20, 2021.**

Learning Objectives:

1. Review our shared CQC vision and improvement objectives
2. Review registry reports focusing on ascites control data
3. Gather concrete change ideas for improving ascites control
4. Connect with peers to exchange ideas and strategies for improvement


This curriculum was developed for Primary Care Providers and any other healthcare provider interested in liver disease.

Hepatologists
Nurses
Nurse Practitioners
Physician Assistants
Fellows/Trainees
Primary Care Physicians
Other healthcare providers

CREDITS OFFERED 
Continuing Medical Education (CME): For a maximum of 1.50 AMA PRA Category 1 Credits™   
Continuing Education (CE): For a maximum of 1.50 Contact Hours

ACCREDITATION AND DESIGNATION STATEMENTS 
Continuing Medical Education (CME) 
The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AASLD designates this enduring activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

image

Continuing Education (Nursing Contact Hours)  
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the American Association for the Study of Liver Diseases.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Credit Designation Statement – Amedco LLC designates this enduring material activity for a maximum of 1.50 ANCC contact hours for nurses. Learners should claim only the credit commensurate with the extent of their participation in the activity.

CLAIMING LIVE CME CREDITS 
Physicians and other health care professionals for a maximum of 1.50 AMA PRA Category 1 Credits™ for this enduring continuing medical education material must completed by November 30, 2021.  

CLAIMING CME CREDITS 
Physicians and other health care professionals for a maximum of 1.50 AMA PRA Category 1 Credits™ for this enduring continuing medical education material must completed by December 19, 2024.

CLAIMING CE CREDITS
Nurses for a maximum of 1.50 ANCC contact hours for this enduring continuing education material must be completed by December 19, 2024

DISCLOSURE OF CONFLICTS OF INTEREST 
AASLD requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Disclosures are collected prior to the start of the educational activity. Any potential conflicts of interest that exist are resolved prior to implementation of the activity. All disclosures are made available and communicated to the leaner prior the activity beginning.

The enduring material organizers, faculty, reviewers and staff have reported the following disclosures:

Christina Clarke, MHA, BSc
Faculty/Organizer
Consulting: Improvement advisor (independent contractor) for the Cirrhosis Quality Collaborative
Independent Contractor: Improvement advisor (independent contractor) for the Cirrhosis Quality Collaborative

Audrey Davis-Owino, MRP
Organizer/Reviewer
Nothing to disclose

Fasiha Kanwal, MD, MSHS, AGAF, FAASLD
Organizer/Reviewer
Grant/Research Support: Gilead Sciences and Merck 

Sheila Tynes, MHA, PMP
Organizer/Reviewer
Nothing to disclose

Michael Volk, MD, MSc, FAASLD
Organizer/Reviewer
Nothing to disclose 

Dominique Clayton 
AASLD Staff
Nothing to disclose

Sheryl Morgan 
Amedco LLC Staff
Nothing to disclose

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of AASLD. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Acknowledgement of Commercial Support: No commercial support was received for this enduring material activity.


Key:

Complete
Failed
Available
Locked
Learning Session II
Recorded 10/19/2021
Recorded 10/19/2021
Evaluation
Evaluation (Complete to claim CME credit)
11 Questions
11 Questions Please complete the following evaluation form to share your feedback on this activity.
Claim your LIVE continuing education credit
Up to 1.50 medical credits available  |  Certificate available
Up to 1.50 medical credits available  |  Certificate available Select the number of credit hours based on your attendance. Learner should claim credits in .25-hour increments (i.e.: .25, .50, .75, 1.00, 1.25, etc.).
Claim your continuing education credit
Up to 1.50 medical credits available  |  Certificate available
Up to 1.50 medical credits available  |  Certificate available Select the number of credit hours based on your attendance. Learner should claim credits in .25-hour increments (i.e.: .25, .50, .75, 1.00, 1.25, etc.).